Iradimed (IRMD) Accumulated Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Accumulated Expenses data on file, last reported at $2.1 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $2.1 million, up 1641.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (up 1641.99% YoY), and the FY2025 annual result was $144000.0, up 22.03% from the prior year.
• Accumulated Expenses rose to $2.1 million in Q1 2026 per IRMD's latest filing, from $144000.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $3.3 million in Q3 2024 and troughed at $94030.0 in Q4 2022.
• A 5-year average of $1.3 million and a median of $1.6 million in 2023 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses surged 2214.84% in 2023, then plunged 95.83% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $94030.0 in 2022, then advanced by 24.92% to $117463.0 in 2023, then advanced by 0.46% to $118000.0 in 2024, then gained by 22.03% to $144000.0 in 2025, then soared by 1334.72% to $2.1 million in 2026.
• Business Quant data shows IRMD's Accumulated Expenses at $2.1 million in Q1 2026, $144000.0 in Q4 2025, and $137025.0 in Q3 2025.